Technical Analysis for SYRE - Spyre Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 36.27 | 7.09% | 2.40 |
SYRE closed up 7.09 percent on Thursday, May 2, 2024, on 73 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
Earnings due: May 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | 0.00% | |
| Crossed Above 50 DMA | Bullish | 0.00% | |
| BB Squeeze Ended | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 7.09% | |
| Bollinger Band Squeeze | Range Contraction | 7.09% | |
| 20 DMA Resistance | Bearish | 9.81% | |
| Fell Below 50 DMA | Bearish | 9.81% | |
| Bollinger Band Squeeze | Range Contraction | 9.81% | |
| Outside Day | Range Expansion | 9.81% |
| Alert | Time |
|---|---|
| Up 1 ATR | about 12 hours ago |
| Rose Above 20 DMA | about 16 hours ago |
| 60 Minute Opening Range Breakout | about 16 hours ago |
| Rose Above 50 DMA | about 16 hours ago |
| Up 5% | about 16 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Spyre Therapeutics is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Immunology Antibodies Autoimmune Disease Monoclonal Antibody Antibody Inflammatory Bowel Disease
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Immunology Antibodies Autoimmune Disease Monoclonal Antibody Antibody Inflammatory Bowel Disease
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 47.97 |
| 52 Week Low | 2.66 |
| Average Volume | 533,902 |
| 200-Day Moving Average | 20.86 |
| 50-Day Moving Average | 35.61 |
| 20-Day Moving Average | 35.38 |
| 10-Day Moving Average | 33.70 |
| Average True Range | 2.98 |
| RSI (14) | 53.49 |
| ADX | 16.04 |
| +DI | 24.02 |
| -DI | 17.22 |
| Chandelier Exit (Long, 3 ATRs) | 31.88 |
| Chandelier Exit (Short, 3 ATRs) | 40.22 |
| Upper Bollinger Bands | 39.62 |
| Lower Bollinger Band | 31.14 |
| Percent B (%b) | 0.6 |
| BandWidth | 23.97 |
| MACD Line | -0.48 |
| MACD Signal Line | -0.43 |
| MACD Histogram | -0.0518 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 41.04 | ||||
| Resistance 3 (R3) | 40.75 | 38.86 | 40.25 | ||
| Resistance 2 (R2) | 38.86 | 37.65 | 39.01 | 39.98 | |
| Resistance 1 (R1) | 37.57 | 36.90 | 38.22 | 37.86 | 39.71 |
| Pivot Point | 35.68 | 35.68 | 36.01 | 35.83 | 35.68 |
| Support 1 (S1) | 34.39 | 34.47 | 35.04 | 34.68 | 32.83 |
| Support 2 (S2) | 32.50 | 33.72 | 32.65 | 32.56 | |
| Support 3 (S3) | 31.21 | 32.50 | 32.30 | ||
| Support 4 (S4) | 31.50 |
